Recently, we found that the levels of CaR, Gα12 and p115RhoGEF expression are significantly up-regulated in AR-deficient and highly metastatic prostate cancer cells and prostate tumor specimens [26]. This evidence concerns the gene ARHGEF1 and prostate neoplasm.